Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets. - Gide, Tuba N.; Pires da Silva, Inês; Quek, Camelia; Ferguson, Peter M.; Batten, Marcel; Shang, Ping; Ahmed, Tasnia; Menzies, Alexander M.; Carlino, Matteo S.; Saw, Robyn P. M.; Thompson, John F.; Scolyer, Richard A.; et al. (Cancers, 2021)